0001415889-22-006159.txt : 20220606 0001415889-22-006159.hdr.sgml : 20220606 20220606164426 ACCESSION NUMBER: 0001415889-22-006159 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220602 FILED AS OF DATE: 20220606 DATE AS OF CHANGE: 20220606 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Neill Gilmore Neil CENTRAL INDEX KEY: 0001742084 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37687 FILM NUMBER: 22998607 MAIL ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Editas Medicine, Inc. CENTRAL INDEX KEY: 0001650664 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 464097528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-401-9000 MAIL ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 4 1 form4-06062022_010612.xml X0306 4 2022-06-02 0001650664 Editas Medicine, Inc. EDIT 0001742084 O'Neill Gilmore Neil C/O EDITAS MEDICINE, INC. 11 HURLEY ST. CAMBRIDGE MA 02141 true true false false CEO Common Stock 2022-06-02 4 A 0 86655 0 A 86655 D Stock Option (right to buy) 11.54 2022-06-02 4 A 0 950209 0 A 2032-06-01 Common Stock 950209 950209 D The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years in equal yearly installments of one-fourth of the shares, with the first such installment to vest on June 2, 2023 continuing through June 2, 2026. This option was granted on June 2, 2022 and is scheduled to vest over four years, with 25% of the shares scheduled to vest on June 2, 2023 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through June 2, 2026. /s/ Gilmore O'Neill 2022-06-06